The stock of ProMIS Neurosciences Inc (PMN) has gone down by -23.08% for the week, with a -17.97% drop in the past month and a -48.71% drop in the past quarter. The volatility ratio for the week is 16.81%, and the volatility levels for the past 30 days are 13.47% for PMN. The simple moving average for the past 20 days is -15.15% for PMN’s stock, with a -49.23% simple moving average for the past 200 days.
Is It Worth Investing in ProMIS Neurosciences Inc (NASDAQ: PMN) Right Now?
The 36-month beta value for PMN is at -0.02. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for PMN is 22.91M, and currently, shorts hold a 0.82% of that float. The average trading volume for PMN on May 09, 2025 was 38.45K shares.
PMN) stock’s latest price update
The stock price of ProMIS Neurosciences Inc (NASDAQ: PMN) has dropped by -10.63 compared to previous close of 0.56. Despite this, the company has seen a fall of -23.08% in its stock price over the last five trading days. globenewswire.com reported 2025-03-31 that Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s Disease
PMN Trading at -24.06% from the 50-Day Moving Average
After a stumble in the market that brought PMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.90% of loss for the given period.
Volatility was left at 13.47%, however, over the last 30 days, the volatility rate increased by 16.81%, as shares sank -11.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -35.06% lower at present.
During the last 5 trading sessions, PMN fell by -23.08%, which changed the moving average for the period of 200-days by -74.09% in comparison to the 20-day moving average, which settled at $0.5893. In addition, ProMIS Neurosciences Inc saw -47.25% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PMN starting from Cashman Neil, who purchase 15,000 shares at the price of $0.97 back on Feb 10 ’25. After this action, Cashman Neil now owns 16,617 shares of ProMIS Neurosciences Inc, valued at $14,595 using the latest closing price.
Shafmaster Madge K., the Director of ProMIS Neurosciences Inc, purchase 70,000 shares at $1.30 during a trade that took place back on Sep 24 ’24, which means that Shafmaster Madge K. is holding 208,333 shares at $91,028 based on the most recent closing price.
Stock Fundamentals for PMN
The total capital return value is set at -1.01. Equity return is now at value 27.46, with 17.08 for asset returns.
Currently, EBITDA for the company is -16.83 billion with net debt to EBITDA at -4.86. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.52.
Conclusion
In conclusion, ProMIS Neurosciences Inc (PMN) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
